retatrutide safety profile vs semaglutide: complete comparison of weight loss, mechanisms, and results Weight loss with retatrutide as

This shows that retatrutide has a good safety profile

doi: 10.1016/j.ejphar.2015.09.029 67 PajaresMRojo AIMandaGBoscLCuadradoA

Go to 0.5mg first

Clinical trial data shows sustained efficacy through 48 weeks

GLP-1 acts through a class 2 member of the G-coupled protein C receptor family seven-transmembrane receptor (GLP-1R) (8), which is mainly expressed in pancreatic islets, the brain, and the gastrointestinal (GI) tract (912), and less prominently in the kidney and eyes (1113)

This leads to multiple metabolic effects, as well as decreasing inflammation and neuroprotective effects.[ref] Two GLP-1 receptor agonists (RAs) currently approved for weight loss are liraglutide and semaglutide